Bugara Klaudia, Pacwa Anna, Smedowski Adrian
Department of Physiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
GlaucoTech Co., Katowice, Poland.
Front Neurosci. 2024 Mar 18;18:1363170. doi: 10.3389/fnins.2024.1363170. eCollection 2024.
Glaucoma is a complex and progressive disease that primarily affects the optic nerve axons, leading to irreversible vision loss. Although the exact molecular mechanisms underlying glaucoma pathogenesis are not fully understood, it is believed that except increased intraocular pressure, a combination of genetic and environmental factors play a role in the development of the disease. Animal models have been widely used in the study of glaucoma, allowing researchers to better understand the underlying mechanisms of the disease and test potential treatments. Several molecular pathways have been implicated in the pathogenesis of glaucoma, including oxidative stress, inflammation, and excitotoxic-induced neurodegeneration. This review summarizes the most important knowledge about molecular mechanisms involved in the glaucoma development. Although much research has been done to better understand the molecular mechanisms underlying this disease, there is still much to be learned to develop effective treatments and prevent vision loss in those affected by glaucoma.
青光眼是一种复杂的进行性疾病,主要影响视神经轴突,导致不可逆的视力丧失。尽管青光眼发病机制的确切分子机制尚未完全明确,但人们认为,除了眼压升高外,遗传和环境因素的综合作用在该疾病的发展中起作用。动物模型已广泛应用于青光眼研究,使研究人员能够更好地理解该疾病的潜在机制并测试潜在的治疗方法。青光眼的发病机制涉及多种分子途径,包括氧化应激、炎症和兴奋性毒性诱导的神经退行性变。本综述总结了有关青光眼发展所涉及分子机制的最重要知识。尽管已经进行了大量研究以更好地理解该疾病的分子机制,但要开发有效的治疗方法并预防青光眼患者的视力丧失仍有许多需要学习的地方。